LXRX | Lexicon Pharmaceuticals, Inc. Annual & Quarterly

Annual Balance Sheets

(In USD)

Breakdown	2023	2022	2021	2020	2019	2018
Total Assets	229.42 Million	194.29 Million	136.9 Million	203.78 Million	417.71 Million	284.13 Million
Total Current Assets	176.54 Million	140.86 Million	88.92 Million	157.71 Million	337.75 Million	173.32 Million
Cash And Short Term Investments	170.02 Million	138.35 Million	86.74 Million	152.27 Million	271.65 Million	160.05 Million
Cash and Cash Equivalents	22.46 Million	46.34 Million	64.06 Million	126.26 Million	36.11 Million	160.05 Million
Short Term Investments	147.56 Million	92.01 Million	22.67 Million	26.01 Million	235.54 Million	79.66 Million
Net Receivables	1.01 Million	28 Thousand	14 Thousand	395 Thousand	56.53 Million	5.92 Million
Inventory	381 Thousand	-	-	1.00	4.24 Million	4.68 Million
Other Current Assets	5.13 Million	2.48 Million	2.16 Million	5.04 Million	5.32 Million	2.66 Million
Total Non-Current Assets	52.88 Million	53.43 Million	47.98 Million	46.06 Million	79.96 Million	110.81 Million
Net PPE	7.51 Million	2.07 Million	1.17 Million	295 Thousand	14.04 Million	15.86 Million
Good Will And Intangible Assets	44.54 Million	44.54 Million	44.54 Million	44.54 Million	64.25 Million	94.66 Million
Good Will	44.54 Million	44.54 Million	44.54 Million	44.54 Million	44.54 Million	44.54 Million
Intangible Assets	-	-	-	-	19.71 Million	50.11 Million
Long-Term Investments	-	-	-	-	-4.14 Million	-4.51 Million
Tax Assets	-	-	-	-	4.14 Million	4.51 Million
Other Non Current Assets	828 Thousand	6.81 Million	2.26 Million	1.23 Million	1.65 Million	285 Thousand
Other Assets	-	-	-	-	-	-
Total Liabilities	136.31 Million	77.17 Million	23.31 Million	47.41 Million	300.61 Million	310.54 Million
Total Current Liabilities	31.54 Million	23.17 Million	22.12 Million	46.8 Million	65.34 Million	36.75 Million
Account Payables	14.38 Million	10.39 Million	9.15 Million	5.46 Million	12.17 Million	17.75 Million
Tax Payables	-	-	-	-	-	-
Short Term Debt	1.29 Million	1.29 Million	1.08 Million	12.19 Million	11.01 Million	1.11 Million
Deferred Revenue	-	-	-	28.16 Million	-	3.39 Million
Other Current Liabilities	15.86 Million	11.48 Million	11.88 Million	976 Thousand	42.15 Million	14.48 Million
Total Non Current Liabilities	104.77 Million	54 Million	1.19 Million	611 Thousand	235.27 Million	273.79 Million
Long-Term Debt	99.5 Million	54 Million	1.19 Million	611 Thousand	235.27 Million	243.88 Million
Deferred Revenue Non Current	-	-	-	-	-5.24 Million	27.04 Million
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	5.26 Million	-	-	-	1.1 Million	-3.15 Million
Other Liabilities	-	-	-	-	-	-
Total Equity	93.11 Million	-1.58 Billion	-1.48 Billion	156.37 Million	-1.34 Billion	-1.47 Billion
Stock Holders Equity	93.11 Million	-1.58 Billion	-1.48 Billion	156.37 Million	-1.34 Billion	-1.47 Billion
Common Stock	245 Thousand	189 Thousand	150 Thousand	142 Thousand	106 Thousand	106 Thousand
Retained Earnings	-1.76 Billion	-1.58 Billion	-1.48 Billion	-1.4 Billion	-1.34 Billion	-1.47 Billion
Accumulated other comprehensive income	31 Thousand	-428 Thousand	-10 Thousand	-6000.00	84 Thousand	-12 Thousand
Common Stock Equity	93.11 Million	-1.58 Billion	-1.48 Billion	156.37 Million	-1.34 Billion	-1.47 Billion
Capital Lease Obligation	5.26 Million	6.71 Million	2.27 Million	1.16 Million	1.1 Million	-
Total Investments	147.56 Million	92.01 Million	22.67 Million	26.01 Million	235.54 Million	79.66 Million
Total Debt	106.06 Million	55.29 Million	2.27 Million	12.81 Million	246.28 Million	245 Million
Net Debt	83.59 Million	8.94 Million	-61.78 Million	-113.45 Million	210.17 Million	84.95 Million

Breakdown	2024 Q2	2024 Q1	2023 FY	2023 Q4	2023 Q3	2023 Q2
Total Assets	373.35 Million	417.21 Million	229.42 Million	229.42 Million	276.47 Million	316.72 Million
Total Current Assets	320.84 Million	364.64 Million	176.54 Million	176.54 Million	223.37 Million	263.72 Million
Cash And Short Term Investments	309.96 Million	355.59 Million	170.02 Million	170.02 Million	218.42 Million	256.73 Million
Cash and Cash Equivalents	35.61 Million	96.49 Million	22.46 Million	22.46 Million	21.11 Million	102.27 Million
Short Term Investments	274.34 Million	259.1 Million	147.56 Million	147.56 Million	197.31 Million	154.46 Million
Net Receivables	2.62 Million	1.52 Million	1.01 Million	1.01 Million	318 Thousand	685 Thousand
Inventory	585 Thousand	514 Thousand	381 Thousand	381 Thousand	336 Thousand	172 Thousand
Other Current Assets	7.67 Million	7 Million	5.13 Million	5.13 Million	4.29 Million	6.12 Million
Total Non-Current Assets	52.51 Million	52.57 Million	52.88 Million	52.88 Million	53.1 Million	53 Million
Net PPE	7.14 Million	7.2 Million	7.51 Million	7.51 Million	2.13 Million	8.46 Million
Good Will And Intangible Assets	44.54 Million	44.54 Million	44.54 Million	44.54 Million	44.54 Million	44.54 Million
Good Will	44.54 Million	44.54 Million	44.54 Million	44.54 Million	44.54 Million	44.54 Million
Intangible Assets	-	-	-	-	-	-
Long-Term Investments	-	-	-	-	-	-
Tax Assets	-	-	-	-	-	-
Other Non Current Assets	828 Thousand	828 Thousand	828 Thousand	828 Thousand	6.43 Million	-53 Million
Other Assets	-	-	-	-	-	-
Total Liabilities	133.37 Million	128.35 Million	136.31 Million	136.31 Million	136.96 Million	130.36 Million
Total Current Liabilities	27.87 Million	23.39 Million	31.54 Million	31.54 Million	32.26 Million	26.1 Million
Account Payables	12.22 Million	8.06 Million	14.38 Million	14.38 Million	12.03 Million	10.5 Million
Tax Payables	-	-	-	-	-	-
Short Term Debt	1.29 Million	1.29 Million	1.29 Million	1.29 Million	1.29 Million	1.29 Million
Deferred Revenue	-	-	-	-	-1.29 Million	-1.29 Million
Other Current Liabilities	14.36 Million	14.04 Million	15.86 Million	15.86 Million	20.22 Million	15.6 Million
Total Non Current Liabilities	105.5 Million	104.95 Million	104.77 Million	104.77 Million	104.7 Million	104.25 Million
Long-Term Debt	99.49 Million	99.87 Million	99.5 Million	99.5 Million	104.7 Million	104.25 Million
Deferred Revenue Non Current	-	-	-	-	-	-
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	6 Million	5.07 Million	5.26 Million	5.26 Million	-	-
Other Liabilities	-	-	-	-	-	-
Total Equity	239.98 Million	288.86 Million	93.11 Million	93.11 Million	-1.71 Billion	-1.66 Billion
Stock Holders Equity	239.98 Million	288.86 Million	93.11 Million	93.11 Million	-1.71 Billion	-1.66 Billion
Common Stock	363 Thousand	248 Thousand	245 Thousand	245 Thousand	245 Thousand	245 Thousand
Retained Earnings	-1.86 Billion	-1.81 Billion	-1.76 Billion	-1.76 Billion	-1.71 Billion	-1.66 Billion
Accumulated other comprehensive income	-193 Thousand	-50 Thousand	31 Thousand	31 Thousand	-113 Thousand	-100 Thousand
Common Stock Equity	239.98 Million	288.86 Million	93.11 Million	93.11 Million	-1.71 Billion	-1.66 Billion
Capital Lease Obligation	4.88 Million	5.07 Million	5.26 Million	5.26 Million	6.73 Million	6.77 Million
Total Investments	274.34 Million	259.1 Million	147.56 Million	147.56 Million	197.31 Million	154.46 Million
Total Debt	105.67 Million	106.24 Million	106.06 Million	106.06 Million	105.99 Million	105.54 Million
Net Debt	70.05 Million	9.75 Million	83.59 Million	83.59 Million	84.88 Million	3.27 Million

Balance Sheet Charts

Notable Labs, Ltd.

NTBL

Full Analysis

Annual Balance Sheets
Quilter plc

QLT

Full Analysis

Annual Balance Sheets
GENUS PRIME INFRA LIMITED

GENUSPRIME

Full Analysis

Annual Balance Sheets
Grand Pharmaceutical Group Limited

0512

Full Analysis

Annual Balance Sheets
Smiths Group plc

SMIN

Full Analysis

Annual Balance Sheets
Elitegroup Computer Systems Co.,Ltd.

2331

Full Analysis

Annual Balance Sheets

Global Stocks Search

Lexicon Pharmaceuticals, Inc. (LXRX)

Annual Balance Sheets

Balance Sheet Charts

Notable Labs, Ltd.

Quilter plc

GENUS PRIME INFRA LIMITED

Grand Pharmaceutical Group Limited

Smiths Group plc

Elitegroup Computer Systems Co.,Ltd.